Piper Sandler raises target for Cigna Group stock from USD 346 to USD 370

Published on 10/06/2026 at 17:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 71.67 billion, up 7.00 percent year over year. Cigna Group stock spans USD 239.51 to USD 312.18.

Farbenfrohe Pop-Art-Comic-Szene in einem Wartezimmer einer Gesundheitsklinik im Retro-60er-Stil — Cigna Group Pop-Art-Comic-Szene im Wartezimmer einer Krankenversicherungsklinik, ISIN US1255231003, Retro-Stil mit Primärfarben, Illustration mit AI erstellt.

The Cigna Group (ISIN US1255231003) received a higher published valuation reference when Piper Sandler raised its price target from USD 346 to USD 370 on October 2, 2026, while maintaining an Overweight rating, according to Yahoo Finance. The move followed the company's September 30 Investor Day, which set a long-term adjusted earnings-per-share growth target of 10.00 percent to 14.00 percent.

Target rises after Investor Day

According to StockTitan, The Cigna Group reaffirmed its 2026 outlook on September 30, 2026. The outlook calls for adjusted earnings per share of at least USD 30.45 and adjusted revenue of USD 280.00 billion for fiscal 2026.

The same filing describes a USD 3.00 billion multi-year modernization and productivity initiative. Management also set a 10.00 percent to 14.00 percent long-term annual adjusted earnings-per-share growth target through 2030, turning the Investor Day into a measurable operating milestone rather than only a strategy presentation.

Second-quarter revenue gains 7.00 percent

The most recent reported quarter supplied a stronger operating baseline. In the second quarter of 2026, total revenue reached USD 71.67 billion, up 7.00 percent from the second quarter of 2025, while shareholders' net income was USD 1.66 billion, according to NadirAlpha. Diluted earnings per share stood at USD 6.29 for that quarter.

The comparison matters because the revenue increase was accompanied by higher adjusted income from operations, which rose 6.00 percent to USD 2.10 billion in the second quarter of 2026, based on the same reported overview. Evernorth Health Services and Cigna Healthcare were both identified as contributors to the quarterly growth.

Market value and trading range

As of October 6, 2026, The Cigna Group had a market capitalization of USD 71.8 billion. Its 52-week range was USD 239.51 to USD 312.18, placing the current valuation reference below the year's high and leaving the analyst target above that high at USD 370.00.

The market case therefore rests on two separate numbers: the latest quarter's 7.00 percent revenue growth and the 10.00 percent to 14.00 percent long-term adjusted earnings-per-share target. For investors, the key test is whether the modernization program can support that target while the two operating divisions continue to expand.